Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Maze Therapeutics
About MAZE
Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in harnessing the power of human genetics and variant functionalization with its Maze Compass platform to develop small-molecule precision medicines for the treatment of renal, cardiovascular and related metabolic diseases, including obesity. The Compass platform has been purpose-built to inform all phases of drug discovery and development process through clinical trial design, advancing two wholly owned lead programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach to chronic kidney disease (CKD). Its lead program, MZE829, is an oral, small-molecule inhibitor of apolipoprotein L1, or APOL1, for the treatment of patients with APOL1 kidney disease, or AKD. Its second lead program, MZE782, is an oral, small-molecule inhibitor of the solute transporter SLC6A19, a novel CKD target.
Find out what a historical investment in Maze Therapeutics would be worth today using our MAZE stock calculator.
Market Capitalisation
$1.41B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
845.11K
High today
$27.06
Low today
$25.33
Open price
$26.00
52-week high
$53.65
52-week low
$8.25
Ready to start your investing journey with Stake?
Open an accountHow do I buy MAZE shares in Australia?
Buying MAZE shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Maze Therapeutics in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in MAZE
What is the ticker symbol of Maze Therapeutics?
The ticker symbol for Maze Therapeutics is MAZE.
How much is one share of MAZE?
One share of MAZE is valued at $26.86 as of 13 May 2026.
What is the market capitalisation of Maze Therapeutics MAZE?
As of 13 May 2026 Maze Therapeutics has a market cap of $1.41B.
What is the 52-week high for Maze Therapeutics stock?
The Maze Therapeutics 52-week high stock price is $53.65.
What is the 52-week low for Maze Therapeutics stock?
The Maze Therapeutics 52-week low stock price is $8.25.
Can I buy MAZE shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy MAZE shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in MAZE on Stake
- Buy MAZE from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of MAZE from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
MAZE related stocks